New hope for tough blood cancers: trial tests promising drug combo
Disease control
Recruiting now
This study is testing a new drug called SLS009 for people with advanced blood cancers that have come back or stopped responding to treatment, and for newly diagnosed patients with high-risk forms of leukemia. The main goals are to find a safe dose and see if the drug, given alone…
Phase: PHASE1, PHASE2 • Sponsor: Sellas Life Sciences Group • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC